Wedbush has assumed coverage of Voyager Therapeutics (NASDAQ:VYGR) with an outperform rating, highlighting the company’s ...

Wedbush upgraded Voyager Therapeutics (VYGR) to Outperform from Neutral with a price target of $11, up from $7, after assuming coverage of the ...

Tesla’s Elon Musk and his close relationship with President-elect Trump are already having a huge impact on the EV maker, ...

Key Takeaways Wedbush upgraded Snowflake as the analysts predicted that the artificial intelligence software era is ...

The EV maker’s stock gained 3.7% on Friday, leaving the shares ahead nearly 40% for the year and giving it a market value of ...

Microsoft stock was lagging its tech peers on Friday as investors reacted to news the company is facing a broad inquiry from ...

Trump previously vowed to end federal electric vehicle tax credits, which are worth up to $7,500 for new zero-emission ...

Apple Inc.’s skeptics and bears have missed the last more than $1 trillion upward move in the stock by overlooking three key dynamics behind the story, Wedbush analysts said Friday. Apple has an ...

We recently compiled a list of the 15 Trending AI Stocks on Latest Ratings and News. In this article, we are going to take a ...

In an interview with CNBC on November 25, Dan Ives, Global Head of Technology Research at Wedbush Securities said that he ...

It’s hard to believe, but it was just two years ago that OpenAI released ChatGPT to the world – and showed us all just how ...